Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys542
Sells10972
Buy $$24.91B
Sell $$16.21B
Ratio1.54:1
% Change vs. Prior
Ratio +367.8%Value +272.9%
Healthcare
Buys621
Sells4795
Buy $$459.66M
Sell $$10.88B
Ratio1:23.68
% Change vs. Prior
Ratio -31.0%Value -25.1%
Industrials
Buys400
Sells2109
Buy $$357.45M
Sell $$7.38B
Ratio1:20.64
% Change vs. Prior
Ratio +141.4%Value +36.9%
Consumer Cyclical
Buys360
Sells2066
Buy $$1.12B
Sell $$4.00B
Ratio1:3.58
% Change vs. Prior
Ratio +4.5%Value +72.2%
Financial Services
Buys1284
Sells2829
Buy $$683.52M
Sell $$4.10B
Ratio1:5.99
% Change vs. Prior
Ratio -20.4%Value -19.2%
Energy
Buys308
Sells439
Buy $$137.67M
Sell $$4.49B
Ratio1:32.60
% Change vs. Prior
Ratio +258.0%Value -17.3%
Consumer Defensive
Buys152
Sells725
Buy $$136.89M
Sell $$2.07B
Ratio1:15.13
% Change vs. Prior
Ratio +89.0%Value +22.2%
Communication Services
Buys132
Sells844
Buy $$157.97M
Sell $$1.32B
Ratio1:8.38
% Change vs. Prior
Ratio +98.1%Value +42.4%
Utilities
Buys69
Sells282
Buy $$73.93M
Sell $$1.39B
Ratio1:18.76
% Change vs. Prior
Ratio +20939.3%Value -78.7%
Basic Materials
Buys126
Sells258
Buy $$62.95M
Sell $$477.42M
Ratio1:7.58
% Change vs. Prior
Ratio -37.1%Value -46.0%
Real Estate
Buys175
Sells325
Buy $$86.95M
Sell $$261.15M
Ratio1:3.00
% Change vs. Prior
Ratio +129.8%Value +0.4%
By Industry
Hardware, Equipment & Parts
Buys22
Sells1101
Buy $$24.59B
Sell $$803.49M
Ratio30.61:1
% Change vs. Prior
Ratio +800.3%Value +809.9%
Software - Infrastructure
Buys57
Sells3702
Buy $$36.75M
Sell $$5.20B
Ratio1:141.53
% Change vs. Prior
Ratio -75.7%Value +197.1%
Medical - Instruments & Supplies
Buys38
Sells111
Buy $$16.34M
Sell $$3.66B
Ratio1:223.95
% Change vs. Prior
Ratio +22.2%Value -52.3%
Semiconductors
Buys110
Sells1803
Buy $$2.84M
Sell $$3.18B
Ratio1:1119.65
% Change vs. Prior
Ratio -77.8%Value +19.9%
Biotechnology
Buys376
Sells3322
Buy $$374.42M
Sell $$2.70B
Ratio1:7.21
% Change vs. Prior
Ratio -57.3%Value +26.3%
Oil & Gas Exploration & Production
Buys182
Sells95
Buy $$48.93M
Sell $$2.65B
Ratio1:54.17
% Change vs. Prior
Ratio +416.8%Value -22.6%
Software - Application
Buys275
Sells1708
Buy $$264.59M
Sell $$2.32B
Ratio1:8.78
% Change vs. Prior
Ratio -62.5%Value +37.4%
Engineering & Construction
Buys13
Sells239
Buy $$1.90M
Sell $$2.34B
Ratio1:1233.52
Computer Hardware
Buys3
Sells1684
Buy $$104.50K
Sell $$2.30B
Ratio1:21971.47
% Change vs. Prior
Ratio -88.8%Value +165.2%
Medical - Healthcare Information Services
Buys33
Sells257
Buy $$18.91M
Sell $$1.93B
Ratio1:102.05
% Change vs. Prior
Ratio -10.7%Value +9.3%
Rental & Leasing Services
Buys7
Sells111
Buy $$2.92M
Sell $$1.87B
Ratio1:642.14
Specialty Retail
Buys81
Sells976
Buy $$22.19M
Sell $$1.65B
Ratio1:74.56
% Change vs. Prior
Ratio -88.9%Value -9.6%
Shell Companies
Buys108
Sells288
Buy $$118.98M
Sell $$1.39B
Ratio1:11.72
Information Technology Services
Buys60
Sells221
Buy $$9.67M
Sell $$1.39B
Ratio1:144.01
Leisure
Buys29
Sells111
Buy $$7.63M
Sell $$1.30B
Ratio1:169.83
Transactions (30326)
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
529
Price
$53.55
Total Value
$28.33K
Shares Held After
15,097
% of Holdings
3.4%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
3,200
Price
$52.78
Total Value
$168.91K
Shares Held After
15,626
% of Holdings
17.0%
Total Return Securities Fund (SWZ)
SELL MORITZ A — Director
Shares
1,853
Price
$5.91
Total Value
$10.95K
Shares Held After
16,155
% of Holdings
11.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
660
Price
$548.90
Total Value
$362.28K
Shares Held After
18,876
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
115
Price
$547.81
Total Value
$63.00K
Shares Held After
19,536
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
265
Price
$547.37
Total Value
$145.05K
Shares Held After
19,651
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$545.19
Total Value
$21.81K
Shares Held After
19,916
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$543.53
Total Value
$21.74K
Shares Held After
19,956
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
192
Price
$541.88
Total Value
$104.04K
Shares Held After
19,996
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
865
Price
$541.06
Total Value
$468.02K
Shares Held After
20,188
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,978
Price
$540.22
Total Value
$1.61M
Shares Held After
21,053
% of Holdings
12.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,035
Price
$539.42
Total Value
$1.10M
Shares Held After
24,031
% of Holdings
7.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,440
Price
$538.31
Total Value
$775.16K
Shares Held After
26,066
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
600
Price
$537.24
Total Value
$322.34K
Shares Held After
27,506
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
210
Price
$536.27
Total Value
$112.62K
Shares Held After
28,106
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
160
Price
$534.48
Total Value
$85.52K
Shares Held After
28,316
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$533.59
Total Value
$213.43K
Shares Held After
28,476
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$552.72
Total Value
$88.44K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$548.84
Total Value
$263.45K
Shares Held After
40,673
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$547.51
Total Value
$175.20K
Shares Held After
41,153
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$545.19
Total Value
$21.81K
Shares Held After
41,473
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$544.01
Total Value
$21.76K
Shares Held After
41,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
613
Price
$541.49
Total Value
$331.94K
Shares Held After
41,553
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$540.52
Total Value
$1.09M
Shares Held After
42,166
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,793
Price
$539.62
Total Value
$1.51M
Shares Held After
44,188
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,399
Price
$538.59
Total Value
$753.49K
Shares Held After
46,981
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
828
Price
$537.52
Total Value
$445.07K
Shares Held After
48,380
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$536.59
Total Value
$131.47K
Shares Held After
49,208
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$535.01
Total Value
$42.80K
Shares Held After
49,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$533.79
Total Value
$256.22K
Shares Held After
49,533
% of Holdings
1.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Bumpus Namandje — Director
Shares
3,963
Price
$3.18
Total Value
$12.60K
Shares Held After
127,632
% of Holdings
3.0%
Anterix Inc. (ATEX)
Lang Scott A. — Director
Shares
170
Price
$80.25
Total Value
$13.64K
Shares Held After
76,527
% of Holdings
0.2%
HERSHEY CO (HSY)
Shares
331
Price
$174.22
Total Value
$57.67K
Shares Held After
1,396,119
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
1,220
Price
$173.33
Total Value
$211.47K
Shares Held After
1,396,450
% of Holdings
0.1%
HERSHEY CO (HSY)
Shares
5,611
Price
$172.47
Total Value
$967.76K
Shares Held After
1,397,670
% of Holdings
0.4%
HERSHEY CO (HSY)
Shares
2,838
Price
$171.66
Total Value
$487.17K
Shares Held After
1,403,281
% of Holdings
0.2%
Xencor Inc (XNCR)
Feigal Ellen — Director
Shares
6,843
Price
$13.06
Total Value
$89.37K
Shares Held After
12,340
% of Holdings
35.7%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
3,000
Price
$6.35
Total Value
$19.05K
Shares Held After
700,000
% of Holdings
0.4%
Shares
44,400
Price
$18.52
Total Value
$822.29K
Shares Held After
120,846
% of Holdings
26.9%
Opera Ltd (OPRA)
Jacobsen Frode — Chief Financial Officer
Shares
44,400
Price
$18.52
Total Value
$822.29K
Shares Held After
43,325
% of Holdings
50.6%
Sleep Number Corp (SNBR)
MENDEZ ANGEL L — Director
Shares
3,020
Price
$0.22
Total Value
$665.91
Shares Held After
34,495
% of Holdings
8.1%
F&M BANK CORP (FMBM)
Willingham John A. — Director
Shares
77
Price
$36.10
Total Value
$2.78K
Shares Held After
21,018
% of Holdings
0.4%
F&M BANK CORP (FMBM)
WRAY PETER H — Director
Shares
171
Price
$36.10
Total Value
$6.17K
Shares Held After
7,745
% of Holdings
2.2%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
1,776
Price
$2.71
Total Value
$4.81K
Shares Held After
390,247
% of Holdings
0.5%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Shields Matthew — EVP, Global Operations
Shares
9,989
Price
$32.19
Total Value
$321.55K
Shares Held After
0
% of Holdings
100.0%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,000
Price
$40.24
Total Value
$402.40K
Shares Held After
16,248
% of Holdings
38.1%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$40.21
Total Value
$603.15K
Shares Held After
1,647
% of Holdings
90.1%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
81,898
Price
$5.99
Total Value
$490.49K
Shares Held After
378,195
% of Holdings
17.8%
Sleep Number Corp (SNBR)
Hellfeld Samuel R — EVP Chief Legal & Risk Officer
Shares
7,964
Price
$0.31
Total Value
$2.47K
Shares Held After
0
% of Holdings
100.0%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,634
Price
$35.39
Total Value
$93.22K
Shares Held After
180,597
% of Holdings
1.4%
Showing 1601–1650 of 30326 transactions (page 33 of 607)